Research Funded To Date

The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.

Since 2008, we have funded 19 separate institutions with over 65 different research grants totaling over $108 million. These grants have involved research in biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.

2009

THE IVY GBM ATLAS PROJECT: ANATOMIC GENE EXPRESSION ATLAS OF HUMAN GLIOBLASTOMA

PIs: Ralph B. Puchalski, Ph.D.
Research Alliance Manager
Allen Institute for Brain Science

Greg Foltz, M.D.
Director, Center for Advanced Brain Tumor Treatment
Swedish Neuroscience Institute

Award: $2,818,946 over four years

IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM

PI:  Michael D. Prados, M.D.
Charles B. Wilson Professor of Neurosurgergery
Professor of Pediatrics (Neuro-Oncology)
Program Leader, Neurological Oncology Program, UCSF Helen Diller Cancer Center
Project Leader, Ivy Foundation Early Phase Clinical Trials Consortium
Project Leader, Pacific Pediatric Neuro-Oncology Consortium
University of California San Francisco (UCSF)

Award: $7,802,786 over nine years

18F PPRGD2 PET/CT, 18F FDG PET/CT AND MRI EVALUATION OF RESPONSE TO ANTI-ANGIOGENESIS THERAPY IN RECURRENT GLIOBLASTOMA MULTIFORME

PIs: Sanjiv Sam Gambhir, M.D., Ph.D.
Head of Radiology and Nuclear Medicine Program
Stanford University

Andrei H. Iagaru, M.D., F.A.C.N.M.
Associate Professor of Radiology
Co-Chief, Nuclear Medicine
Co-Director, Division of Nuclear Medicine and Molecular Imaging
Director, PET-MRI Research Program
Nuclear Medicine Residency Program
Stanford University Medical Center

Award: $1,479,171 over three years

USING GENOMIC SIGNATURES TO PREDICT COMBINATION THERAPY IN GBM

PIs: John H. Sampson, M.D., Ph.D., M.H.Sc.
Associate Professor of Surgery
Associate Deputy Director
Preston Robert Tisch Brain Tumor Center at Duke

Joseph R. Nevins, Ph.D.
Barbara Levine Professor of Cancer Genomics
Director Center for Applied Genomics & Technology
Duke Institute for Genome Sciences & Policy

Award: $2,452,367 over three years

SYSTEMATIC FUNCTIONAL INTERROGATION OF THE GBM GENOME FOR CURATIVE COMBINATION THERAPY

PIs: Ronald A. DePinho, M.D.
Director, Belfer Institute for Applied Cancer Science
Dana-Farber Cancer Institute

Lynda Chin, M.D.
Professor of Dermatology
Harvard Medical School
Dana-Farber Cancer Institute

Award: $2,997,067 over three years
BACK TO TOP
Close Menu